|
|
| 14.59 |  -0.42 / -2.80% |
Data as of 4:00pm ET | Day’s Change |
| 14.59 |  0.00 / 0.00% |
Volume: 8.9K |
| Momenta Pharmaceuticals Inc. Stock Downgraded (MNTA) Mar 04 / TheStreet.com |
| Previous close | 15.01 |
| Today’s open | 14.97 |
| Day’s range | 14.40 - 15.10 |
| Volume | 562,769 |
| Average volume (3 months) | 596,223 |
| Market cap | $787.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -83.62% |
| Earnings growth (this year) | +166.93% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -44.52% |
| P/E ratio | NM |
| Price/Sales | 25.38 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| ONVOOrganovo Holdings In... | -0.45 | -4.64% |
| BCRXBioCryst Pharmaceuti... | +0.02 | +0.17% |
| SZYMSolazyme Inc | -0.09 | -0.66% |
| BLUEbluebird bio Inc | +0.22 | +0.85% |
| Next reporting date | May 8, 2014 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $35.5M |
| Annual profit (last year) | -$108.4M |
| Net profit margin | -305.68% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Craig A. Wheeler |
Chief Financial Officer, Director & Senior VP Richard P. Shea |
Corporate headquarters Cambridge, Massachusetts |
.
